gIcare Pharma

gIcare Pharma Inc, founded in 2011, is a biopharmaceutical startup company developing novel gastrointestinal drugs. Led by dynamic management with extensive experience in gastrointestinal pharmacology, the company aims to develop innovative drugs that address currently unmet medical needs. While innovation should primarily benefit patients, gIcare Pharma believes that any new drug should also provide clinical benefits to doctors and pharmacoeconomic advantages to third-party payers. gIcare's flagship candidate drug, GIC-1001, combines these multi-level benefits and is the best example of what innovation means to us.